92
Participants
Start Date
September 30, 2009
Primary Completion Date
May 31, 2013
Study Completion Date
May 31, 2013
cyclosporin (Neoral)
Neoral capsules bid, Doses were to be adjusted as necessary to achieve and maintain recommended C0 (monitoring of trough levels) or C2 concentration 2 hours post dosing) target ranges
tacrolimus (Prograf)
Tacrolimus capsules bid, doses were adjusted as necessary to achieve and maintain recommended C0 target ranges.
Novartis Investigative Site, Brussels
Novartis Investigative Site, Zurich
Novartis Investigative Site, Santiago de Compostela
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Toulouse
Novartis Investigative Site, Gainesville
Novartis Investigative Site, Oviedo
Novartis Investigative Site, Udine
Novartis Investigative Site, Montpellier
Novartis Investigative Site, Padua
Novartis Investigative Site, Bologna
Novartis Investigative Site, Valladolid
Novartis Investigative Site, Madison
Novartis Investigative Site, Mainz
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Lyon
Novartis Investigative Site, Oklahoma City
Novartis Investigative Site, Paris
Novartis Investigative Site, Houston
Novartis Investigative Site, München
Novartis Investigative Site, Phoenix
Novartis Investigative Site, Créteil
Novartis Investigative Site, Villejuif
Novartis Investigative Site, Palo Alto
Novartis Investigative Site, Bogotá
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, San Francisco
Novartis Investigative Site, Chapel Hill
Novartis Investigative Site, Houston
Novartis Investigative Site, Fortaleza
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Edmonton
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Winnipeg
Novartis Investigative Site, London
Novartis Investigative Site, Toronto
Novartis Investigative Site, Bogotá
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Birmingham
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY